BEUDAMED
    127 results · 21ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

    Lenses, Soft Contact, Extended Wear

    FDA Pre-Market Approval
    FDA Class 3 ·TORAY SOFT CONTACT LENSES

    Lenses, Soft Contact, Extended Wear

    FDA Pre-Market Approval
    FDA Class 3 ·TORAY SOFT CONTACT LENSES

    Lenses, Soft Contact, Extended Wear

    FDA Pre-Market Approval
    FDA Class 3 ·TORAY SOFT CONTACT LENSES

    Two Striper

    FDA UDI
    ABRASIVE TECHNOLOGY, INC.·B868C8400441·Abrasive Point

    iNSitu™ Hip System

    FDA UDI
    NEXTSTEP ARTHROPEDIX, LLC·00816127021008·Quick Connect Cup Trial Size 44

    NUCLEUS 22 CHANNEL COCHLEAR IMPLANT SYSTEM

    FDA Adverse Event
    Malfunction ·COCHLEAR LTD.·Product code MCM·August 23, 2016

    SDI PREPAX DILUKIT 29-1000

    FDA 510(k)
    FDA Class 1 ·Clinical Chemistry

    NUCLEUS 22

    FDA Adverse Event
    Injury ·COCHLEAR LIMITED·Product code MCM·May 18, 2025

    Device, Hemostasis, Vascular

    FDA Pre-Market Approval
    FDA Class 3 ·MATRIX VASCULAR CLOSURE SYSTEM (VSG)

    Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation

    FDA Pre-Market Approval
    FDA Class 3 ·Globe® Pulsed Field System

    SYSLOC MINI AVF 15G X 1" BE 30CM /CLAMP

    FDA Adverse Event
    Injury ·JMS SINGAPORE PTE LTD·Product code FIE·May 30, 2014

    ONETOUCHPING GLUCOSEMGMTSYSTEM

    FDA Adverse Event
    Injury ·ANIMAS CORPORATION·Product code LZG·November 20, 2012

    LEAD MODEL UNK

    FDA Adverse Event
    Malfunction ·CYBERONICS, INC.·Product code LYJ·September 15, 2010

    SULOX HEAD, M, A, 28/0, TAPER 12/14

    FDA Adverse Event
    Injury ·ZIMMER GMBH·Product code LZO·September 8, 2017

    Device, Hemostasis, Vascular

    FDA Pre-Market Approval
    FDA Class 3 ·MYNX VASCULAR CLOSURE DEVICE

    Device, Hemostasis, Vascular

    FDA Pre-Market Approval
    FDA Class 3 ·MynxGrip Vascular Closure Device, Mynx Control Vascular Closure Device (VCD)

    Device, Hemostasis, Vascular

    FDA Pre-Market Approval
    FDA Class 3 ·MYNX VASCULAR CLOSURE DEVICE

    Device, Hemostasis, Vascular

    FDA Pre-Market Approval
    FDA Class 3 ·MynxGrip Vascular Closure Device and two components of Mynx Control Vascular Closure Device (VCD)

    Device, Hemostasis, Vascular

    FDA Pre-Market Approval
    FDA Class 3 ·MYNX VASCULAR CLOSURE DEVICE

    Device, Hemostasis, Vascular

    FDA Pre-Market Approval
    FDA Class 3 ·MYNX VASCULAR CLOSURE DEVICE